Nicousamide

TargetMol
Product Code: TAR-T28170
Supplier: TargetMol
CodeSizePrice
TAR-T28170-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28170-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28170-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Nicousamide, a TGF-β inhibitor, is used potentially for the treatment of renal insufficiency.
CAS:
704881-43-6
Formula:
C18H12N2O9
Molecular Weight:
400.299
Purity:
0.98
SMILES:
Cc1c(O)c(cc2cc(C(=O)Nc3ccc(O)c(c3)C(O)=O)c(=O)oc12)[N+]([O-])=O

References

1. Qi W, Zhao Q, Liu H, Jiang J, Chen X, Hu P. Determination of nicousamide in human plasma by liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal. 2013 Apr 15;77:158-62. doi: 10.1016/j.jpba.2013.01.025. Epub 2013 Jan 26. PubMed PMID: 23416370. 2. Zhang S, Li H, Li Y, Zhang F, Liu Y, Chen X. Nicousamide normalizes renovascular hypertension in two-kidney one-clip hypertensive rats. Biomed Rep. 2013 Jan;1(1):89-92. Epub 2012 Oct 22. PubMed PMID: 24648900; PubMed Central PMCID: PMC3956876. 3. Li H, Zhang Y, Wang H, Zheng X, Chen X. Nicousamide blocks the effects of advanced glycation end products on renal cells. Eur J Pharmacol. 2012 Jan 15;674(2-3):455-9. doi: 10.1016/j.ejphar.2011.06.056. Epub 2011 Jul 13. PubMed PMID: 21763303. 4. Sheng L, Hu JP, Chen H, Li Y. [Metabolism of nicousamide in rat and human liver in vitro]. Yao Xue Xue Bao. 2008 Sep;43(9):912-6. Chinese. PubMed PMID: 19048781.